Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: A double-blind, randomized, placebo-controlled trial

Bipolar Disorders

Volumn 8, Issue 5 I, 2006, Pages 485-489

  Akhondzadeh, Shahin ^a,b   Milajerdi, Mehdi Rafiee ^a   Amini, Homayoun ^a   Tehrani Doost, Mehdi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Adenosine; Allopurinol; Mania

Indexed keywords

ALLOPURINOL; HALOPERIDOL; LITHIUM; PLACEBO; RISPERIDONE;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGITATION; ARTICLE; ASTHENIA; BODY WEIGHT DISORDER; CHECKLIST; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HOSPITALIZATION; HUMAN; INCREASED APPETITE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MANIA; MEDICAL RECORD; NERVOUSNESS; PAIN; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHIATRY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESIDENCY EDUCATION; SCORING SYSTEM; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; TREATMENT OUTCOME; XEROSTOMIA;

ACUTE DISEASE; ADULT; ALLOPURINOL; ANTIMANIC AGENTS; BASAL GANGLIA DISEASES; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HALOPERIDOL; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 33749853968     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2006.00363.x     Document Type: Article

References (20)

1. Tohen M, Grundy S. Management of acute mania. J Clin Psychiatry 1999; 60 (Suppl 5): 31-34.
2. McElory SL, Keck PE, Strakowski SM. Mania, psychosis, and antipsychotics. J Clin Psychiatry 1996; 57 (Suppl 3): 14-26.
3. Tohen M, Zarate CA. Antipsychotic agents and bipolar disorder. J Clin Psychiatry 1998; 59 (Suppl 1): 38-48.
4. Tohen M, Chengappa R, Suppes T et al. Efficacy of olanzepine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002; 59: 62-69.
5. Machado-Viera R, Lara D, Sousa D, Kapczinski F. Purinergic dysfunction in mania: An integrative model. Med Hypotheses 2002; 2: 297-304.
6. Waldeck B. Effect of caffeine on locomotor activity and central catecholamine mechanisms: A study with special references to drug interaction. Acta Pharmacol Toxicol 1975; 36: 1-23.
7. Sawyer DA, Julia HL, Turin AC. Caffeine and human behavior: Arousal, anxiety, and performance effects. J Behav Med 1982; 5: 415-439.
8. Zwyguizen-Doorenbos A, Roehrs T, Lipschutz L, Timms V, Roth T. Effects of caffeine on alertness. Psychopharmacol 1990; 100: 36-39.
9. Stone TW. Physiological roles for adenosine and adenosine 5-triphosphate in the nervous system. Neuroscience 1981; 6: 523-550.
10. Stone TW. Purine receptor classification: A discussion point. Trends in Pharmacol Sci 1985; 5: 492-493.
11. Guieu R, Couraud F, Pouget J, Sampieri F, Bechis G, Rochat H. Adenosine and the nervous system: Clinical implications. Clin Neuropharmacol 1996; 19: 459-474.
12. Brundege JM, Dunwiddie TV. Role of adenosine as a modulator of synaptic activity in the central nervous system. Advances in Pharmacol 1997; 39: 353-391.
13. Machado-Viera R, Lara D, Sousa D, Kapczinski F. Therapeutic efficacy of allopurinol in mania associated with hyperuricemia. J Clin Psychopharmacol 2001; 21: 621-622.
14. Erfurth A, Schmauss M. Perspectives on the therapy of neuropsychiatric diseases with adenosinergic substances. Fortscher Neurol Psychiatry 1995; 63: 93-98.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM IV), 4th edn. Washington, DC: American Psychiatric Press, 1994.
16. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 61: 638-642.
17. World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects, 2000. Available at: http://www.wma.net.
18. Chouinard G, Ross-Chouinard A, Annables L, Jones BD. Extrapyramidal symptoms rating scale (abstract). Can J Neurol Sci 1980; 7: 233.
19. Wada Y, Hasegawa H, Nakamura M, Yamaguchi N. Anticonvulsant effect of allopurinol on hippocampal-kindled seizures. Pharmacol Biochem Behav 1992; 42: 899-901.
20. Lyoo IK, Demopulos CM, Hirashima F, Ahn KH, Renshaw PF. Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: A double-blind trial using proton and lithium magnetic resonance spectroscopy. Bipolar Disord 2003; 5: 300-306.